Article
Making medical decisions in dependence of genetic background: estimation of the utility of DNA testing in clinical, pharmaco-epidemiological or genetic studies.
Genetic epidemiology - 1 May 2013
Nguyen Thuy Trang, Schäfer Helmut, Timmesfeld Nina
Abstract excerpt
An index measuring the utility of testing a DNA marker before deciding between two alternative treatments is proposed which can be estimated from pharmaco-epidemiological case-control or cohort studies. In the case-control design, external estimates of the prevalence of the disease and of the frequency of the genetic risk variant are required for estimating the utility index. Formulas for point and interval...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
